Hospital multidisciplinary team meeting

Hospital multidisciplinary team meeting has been studied in 1 paper since 2025: 1 observational study in people. The newest paper, Sep 29, 2025: “Multidisciplinary team for antithrombotics management and clinical outcomes in older adults with atrial fibrillation: a target trial emulation”.

Exposure

1 paper studies it1 findingUpdated

See all 1 papers on hospital multidisciplinary team meeting

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“risk difference - 0.9 (95% CI, - 7.5 to 6.0); p = .79”
Multidisciplinary team for antithrombotics management and clinical outcomes in older adults with atrial fibrillation: a target trial emulationBMC medicine2025doi:10.1186/s12916-025-04291-9
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funder: Agence Régionale de Santé Île-de-France
  • Humans1

What did studies of hospital multidisciplinary team meeting find?

1

Studies of hospital multidisciplinary team meeting measured one outcome, all-cause death, major thromboembolic events, or major or clinically relevant bleeding.

All-cause death, major thromboembolic events, or major or clinically relevant bleeding

no changein humans1

1 study
  1. Hospital multidisciplinary team meeting was not clearly linked with all-cause death, major thromboembolic events, or major or clinically relevant bleeding in humans (atrial fibrillation or atrial flutter) (RD -0.9% (95% CI -7.5 to 6.0), p = .79).

    “risk difference - 0.9 (95% CI, - 7.5 to 6.0); p = .79”

    Humansatrial fibrillation or atrial flutter6 monthsn = 818

    Multidisciplinary team for antithrombotics management and clinical outcomes in older adults with atrial fibrillation: a target trial emulation

    BMC medicine

Latest